Neuroprotective Effects of Phenothiazines on Acute Ischemic Stroke
Open Access
- 9 June 2026
- journal article
- review article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (6) , e70960
Abstract
Background: Standard therapeutic strategies for acute ischemic stroke (AIS) include endovascular mechanical thrombectomy, intravenous thrombolysis, bridging therapy, and conventional conservative treatment. Despite the implementation of standardized treatments, nearly half of patients still experience significant motor or speech dysfunction, severely impacting their quality of life. Consequently, there is a pressing need for effective neuroprotective adjunctive therapies to further improve functional outcomes and prognosis. Phenothiazines, primarily chlorpromazine and promethazine (C + P), have been proposed as potential neuroprotective agents. Preclinical evidence suggests that phenothiazines may induce mild hypothermic responses, exert anti‐inflammatory effects, and promote a hypometabolic state, thereby potentially contributing to improved neurological outcomes. Methods: We reviewed and synthesized the mechanisms underlying the neuroprotective effects of phenothiazines, with a particular focus on C + P. Results: This review highlights the neuroprotective mechanisms of phenothiazines related to mild hypothermia, anti‐inflammation, and metabolic reduction, along with relevant preclinical and clinical evidence. We also compare the distinct mechanisms of action between C + P and conventional anesthetic sedatives and draw partial comparisons with natural hibernation. Our findings reveal that C + P possesses unique features and advantages in neuroprotection, particularly regarding metabolic suppression and hypothermia. Conclusions: This review explores the adjunctive role of phenothiazines following AIS and elucidates their modulatory mechanisms, which may exert neuroprotective effects through multiple pathways and potentially improve AIS outcomes. This approach may facilitate the identification of novel specific targets for conventional drugs, thereby offering a new perspective on addressing the challenges associated with AIS.Keywords
Funding Information
- National Natural Science Foundation of China (82027802)
- National Natural Science Foundation of China (82071468)
- National Natural Science Foundation of China (82201618)
This publication has 68 references indexed in Scilit:
- Expression of lactate dehydrogenase A and B genes in different tissues of rats adapted to chronic hypobaric hypoxiaJournal of Cellular Biochemistry, 2003
- Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseasesFree Radical Biology and Medicine, 2001
- Adverse Sedation Events in Pediatrics: Analysis of Medications Used for SedationPediatrics, 2000
- Indications for Early Aspirin Use in Acute Ischemic StrokeStroke, 2000
- Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cellsNeuroscience Letters, 1999
- Adenosine and Anoxia Reduce N-Methyl-D-Aspartate Receptor Open Probability in Turtle CerebrocortexJournal of Experimental Biology, 1998
- Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats.Stroke, 1994
- Effects of promethazine on the energy metabolism of normoxic and hypoxic rat brain.Stroke, 1982
- Modification of d-amphetamine- or chlorpromazine-induced hypothermia by β-endorphin, MIF-I, and α-MSH: Mediation by the dopaminergic systemPeptides, 1982
- Influence of “Lytic Cocktail” on Blood Flow and Oxygen Consumption in the Rat BrainActa Anaesthesiologica Scandinavica, 1978